Sphere Bio launches Cyto-Cellect Human IgG Kappa and Viability Assay Kit for efficient single-cell selection

First multiplexed solution introduced with the next-generation Cyto-Mine Chroma platform for more efficient biotherapeutic development Utilizes advanced picodroplet microfluidics technology to integrate analysis of antibody productivity and cell viability of monocl

FairJourney Biologics establishes Supervisory Board

Werner Lanthaler appointed as Chair and joined by global industry leadersThe Supervisory Board will define key avenues for growth, accelerate innovation, and optimize scientific strategies to maintain leadership in antibody discovery and development

Owlstone Medical announces investment of up to $2.3 Million USD from the Cystic Fibrosis Foundation to develop a breath test for Pseudomonas aeruginosa detection in Cystic Fibrosis patients

Test to be developed for Pseudomonas aeruginosa detection in patients with cystic fibrosis suitable for both detection of new cases and monitoring of chronic infection Support to demonstrate proof of principle in chronic infection to be provided to Owlstone in the

US Patent Office grants Closed Loop Medicine key patents for cardiometabolic capabilities in GLP-1 and Direct Oral Anti-Coagulants (DOAC) therapies

London, UK, 24 March 2025: Closed Loop Medicine Ltd., a leader in AI-enabled precision medicines, announces the expansion of its US patent portfolio.

Sapio Sciences makes AI-native drug discovery seamless with NVIDIA BioNeMo

Integration of the NVIDIA BioNeMo platform enhances AI capabilities across the drug discovery lifecycle

SolasCure enrols first patient in a next Phase II clinical trial to advance Aurase Wound Gel

Phase II clinical trial to determine the efficacy of Aurase Wound Gel at a higher concentration of the active enzyme Tarumase in venous leg ulcers

Bio-Rad launches XP-Design Assay Salmonella Serotyping Solution for rapid and accurate food safety testing

HERCULES, Calif. — 10 March  Bio-Rad Laboratories, Inc., a global leader in life science research and clinical diagnostics products, announces the launch of XP-Design Assay Salmonella Serotyping Solution designed for the rapid detection and precise characterization of

H.E.L Group signs research agreement with the Institute of Chemical Technology (ICT) in Mumbai

Collaboration with ICT Mumbai will focus on advancing process safety and chemical synthesis in India

Shift Bioscience announces key appointments to advance rejuvenation therapeutics pipeline

Jill Reckless (CEO, RxCelerate) appointed as Translation Advisor Laurence Reid joins as Non-Executive Director, previously Decibel Therapeutics, Warp Drive Bio, Alnylam, and Millennium Pharmaceuticals

Cambridge, UK, 12 March 2025:&

OBN invites life science R&D companies, industry leaders, academics, and investors to BioTrinity 2025

Opening keynote from Tim Haines, Executive Partner at Abingworth, to provide a review of the life science investment landscapeExpected to welcome c900 delegates [SB1] spanning early-stage life science R&D,

TRIMTECH Therapeutics raises $31M seed funding to advance targeted protein degradation pipeline for treatment of neurodegenerative diseases

Oversubscribed financing led by Cambridge Innovation Capital and SV Health Investors’ Dementia Discovery Fund with M Ventures and Pfizer Ventures joining Investment will support further development of CNS penetrant therapeutics based on the Company’s TRIMTACTM

Centauri Therapeutics selects first clinical candidate, for immunotherapeutic treatment of Gram-negative bacterial infections

Lead candidate in the ABX-01 programme to progress into first-in-human clinical studies Programme designed to treat Gram-negative bacterial lung infections in the most vulnerable patients

London, UK, 4 March 2025: Centauri Therapeu

FairJourney Biologics acquires Charles River Laboratories South San Francisco facility

Acquisition of Charles River site, previously Distributed Bio, strengthens antibody discovery capabilities with SuperHuman libraries and Yeast Display platformEstablished presence in major North American biotechnology cluster extends FairJourney’s global reach 

Nuclera appoints Seth Benson as Chief Financial Officer

Appointment to drive commercial growth of eProtein Discovery and support strategic expansion

Sapio Sciences expands leadership team to drive growth

Mike Hampton Joins as Chief Commercial Officer, and New Scientific Office Strengthens Sapio’s AI-Driven Lab Informatics Leadership

Shift Bioscience establishes North American facilities to expand capabilities of AI-powered virtual cell technology

Head of Machine Learning, Lucas Camillo, to lead team with Professor Bo Wang, University of Toronto, appointed as Senior AdvisorExpansion into global AI hub to accelerate growth of IP portfolio and progress toward key technical milestones 

Nuclera appoints William J. Kullback as Non-Executive Director

Appointment of leading financial executive supports continued commercial development Current CFO at Telesis Bio, former CFO of BioLegend Inc.

Cambridge, UK, 18 February 2025: Nuclera, the biotechnology company accelerating protein

Antibodies.com and Cactus Communications partner to accelerate life science manuscript publication

Partnership provides Antibodies.com’s network of scientists with access to CACTUS’ editorial and publishing services to improve manuscript quality and increase publication success

Gyros Protein Technologies introduces Gyrolab HEK293 HCP Type SN and Type CL Kit Reagents to support biotherapeutic development

Ready-to-use kits expand portfolio of host cell protein impurity kits, for quantification of host cell proteins from HEK293 cell lines Kits developed through a collaboration with BioGenes GmbH 

Uppsala, Sweden, 05 February 2025:

Sapio Sciences selected by LabConnect to transform laboratory operations

Sapio LIMS to enhance research workflows, improve data integrity, and support scalable innovation

Trilobio introduces whole-laboratory automation platform at SLAS2025

·        First public demonstration of unified robotics, device and software platform to be showcased at SLAS2025, 25-29 January, in San Diego, CA. Booth 2115

Schrödinger Selects Sapio Sciences to Enhance In Silico Drug Discovery From Plasmid to Structure

Configurable informatics platform improves lab efficiency, data tracking, and resource management from plasmid to structure

Bio-Rad launches TrailBlazer Tag and TrailBlazer StarBright Dye Label Kits for Antibody Conjugation to StarBright Dyes

New Kits Offer Broad Antibody Compatibility and Long-Term Stability for Flow Cytometry and Western Blot Applications

Tecan introduces Veya: bringing digital, scalable automation to labs worldwide

Multiomics platform streamlines workflows and provides real-time insights, optimizing resource usage and ensuring smooth, data-driven operations

Artificial Inc. proof-of-concept data demonstrates platform capabilities with NVIDIA’s BioNeMo

Collaborative project with world leader in AI computing demonstrates Artificial workflows and model integration for self-driving generative virtual screening in drug discovery Company also announces key accreditations in recognition of excellence in data security,